Macrocapsules as a novel alternative for systemic in vivo delivery of virus vector

Minerva Biotecnologica

Volumn 12, Issue 4, 2000, Pages 305-308

  Saller, R M ^a   Stange, J ^a   Mitzner, S ^a   Von Rombs, K ^a   Hutzler, P ^a   Dautzenberg, H ^a   Gunburg W H ^a   Salmons, B ^a  

^a Bavarian Nordic GmbH   (Germany)

Author keywords

Cellulose sulphate; Gene therapy; Microencapsulation; Retroviral vector

Indexed keywords

CELLULOSE PHOSPHATE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CELL SURVIVAL; CONTINUOUS INFUSION; DRUG CAPSULE; DRUG RELEASE; ENCAPSULATION; GENE TARGETING; GENE THERAPY; HALF LIFE TIME; IN VITRO STUDY; IN VIVO STUDY; MICROCAPSULE; MOUSE; MOUSE STRAIN; NONHUMAN; RETROVIRUS; SYSTEMIC CIRCULATION;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0034461464     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Microencapsulation of recombinant cells: A new delivery system for gene therapy
2. Nonautologous somatic gene therapy
3. Polymer encapsulated cells genetically modified to secrete human nerve growth promote the survival of axotomized septal cholinergic neurons
4. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF
5. Retroviral vectors directed to predefined cell types for gene therapy
6. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450
7. Prolonged biochemical and morphological stability of encapsulated liver cells - A new method
8. Encapsulated cells producing retroviral vectors for in vivo gene therapy
9. Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells